SocialPicks Monitor new  |    Stock Idea Community
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
Investment Ideas Served Daily By People You Trust
SocialPicks is a community where stock investors exchange ideas and track performance of financial bloggers.
Top_member_photos
Get free stock picks and email alerts daily
 
Are you a stock guru?

3 pts

Opinion on  Pharmaceutical HOLDRs Trust Pharmaceutical HOLDRs Trust (PPH)     Sector: Financial  >  Industry: Misc. Financial Services
Updated FDA Calendar of Decision Dates

Oct 04, 2008 12:04 AM UTC
Rxlogo
Return Risk
-6.40% MID
Principal

Company Name Ticker Date   FDA Decision - Mike Havrilla - Updated 10/3/08
Ligand Pharma LGND 9/19/08 Promacta NDA
GlaxoSmithKline GSK 9/19/08 Promacta NDA
Abbott Labs ABT 9/21/08 Vicodin CR NDA
Eli Lilly LLY 9/26/08 prasugrel (Effient) NDA
Daiichi Sankyo Tokyo: 4568 9/26/08 prasugrel (Effient) NDA
ViroPharma VPHM 10/14/08 Cinryze Class II Resubmission
AMAG Pharma AMAG 10/19/08 ferumoxytol NDA
Teva Pharma TEVA 10/24/08 Lo Seasonique NDA
Cypress Bioscience CYPB 10/31/08 milnacipran NDA
Salix Pharma SLXP 10/31/08 granulated mesalamine (QD) NDA
Cephalon CEPH 10/31/08 Treanda NDA for NHL
Forest Labs FRX 10/31/08 milnacipran NDA
Abbott Labs ABT 10/31/08 TriLipix NDA
Solvay Brussells: SOLB 10/31/08 TriLipix NDA
Takeda Tokyo: 4502 11/3/08 TAK-390MR NDA
Takeda Tokyo: 4502 11/7/08 alogliptin NDA
Pharma Prod Devlmt PPDI 11/7/08 alogliptin NDA
Pfizer PFE 11/15/08 Fablyn NDA
Ligand Pharma LGND 11/15/08 Fablyn NDA
Johnson & Johnson JNJ 11/23/08 Tapentadol NDA
Genzyme GENZ 11/29/08 Myozyme (2000L scale) BLA  
AstraZeneca AZN 11/30/08 Motavizumab BLA
Somaxon SOMX 12/1/08 Silenor NDA
Genta OTCBB: GNTA 12/3/08 Genasense Class 2 Resubmission
UCB Group Brussells: UCB 12/6/08 Cimzia BLA - rheumatoid arthritis
Targanta TARG 12/8/08 Oritavancin NDA
Pain Therapeutics PTIE 12/10/08 Remoxy NDA
King Pharma KG 12/10/08 Remoxy NDA
Watson Pharma WPI 12/12/08 silodosin NDA
Genzyme GENZ 12/16/08 Mozobil NDA
NovaDel Pharma NVD 12/19/08 ZolpiMist 505(b)(2) (zolpidem oral spray)
Sciele Pharma SCRX 12/19/08 CloniBID NDA
Genzyme GENZ 12/23/08 Synvisc-ONE PMA
Alpharma ALO 12/30/08 Embeda NDA
Epix Pharma EPIX 12/30/08 Vasovist NDA
Johnson & Johnson JNJ 12/31/08 ustekinumab BLA
Medarex MEDX 12/31/08 ustekinumab BLA
Labopharm DDSS 1/2/09 Once-Daily Tramadol NDA - Class 2 Response
CSL Limited Australia: CSL 1/6/09 C1-INH BLA
Anesiva ANSV 1/10/09 Zingo sNDA
Ipsen SA Paris: IPN 1/17/09 Reloxin BLA
Medicis Pharma MRX 1/17/09 Reloxin BLA
Arpida Ltd. Munich: ADF 1/19/09 iclaprim NDA
Sanofi-Aventis SNY 1/31/09 Multaq NDA
GTC Biotherapeutics GTCB 2/7/09 Atryn BLA
Alkermes ALKS 2/14/09 Risperdal Consta sNDA
Johnson & Johnson JNJ 2/14/09 Risperdal Consta sNDA
Acusphere ACUS 2/28/09 Imagify NDA
AstraZeneca AZN 2/28/09 Symbicort sNDA
ImClone Systems IMCL 3/1/09 Erbitux sBLA
Bristol-Myers BMY 3/1/09 Erbitux sBLA
Basilea Pharma Switzerland: BSLN 3/15/09 ceftobiprole NDA class 2 response
Johnson & Johnson JNJ 3/15/09 ceftobiprole NDA class 2 response
Dyax DYAX 3/24/09 DX-88 BLA
Johnson & Johnson JNJ 3/27/09 golimumab (CNTO 148) BLA
Watson Pharma WPI 3/28/09 oxybutynin gel NDA
GlaxoSmithKline GSK 3/29/09 casopitant NDA
Novo Nordisk NVO 3/30/09 liraglutide NDA
Cell Therapeutics CTIC 4/2/09 Zevalin sBLA (priority review requested)
Bristol-Myers BMY 4/30/09 Onglyza NDA
Astra Zeneca AZN 4/30/09 Onglyza NDA
United Therapeutics UTHR 4/30/09 inhaled treprostinil NDA
Johnson & Johnson JNJ 5/30/09 Xarelto NDA (with Bayer)
H. Lundbeck Denmark: LUN 7/15/09 Serdolect NDA
XenoPort XNPT 7/16/09 Solzira NDA
GlaxoSmithKline GSK 7/16/09 Solzira NDA
Labopharm DDSS 7/22/09 rapid-onset trazodone (DDS-04A) 505(b)(2)
Takeda Tokyo: 4502 7/23/09 Alogliptin + Actos Combo Tablet NDA
Adv. Life Sciences ADLS 8/1/09 Cethromycin NDA
Medivir Sweden: MVIRB 8/1/09 Lipsovir NDA


PPH:  This call was made on 10/04/08 @ $64.39
Rating:   Positive   $64.39 (10/04/08)
Closed:   10/15/2008 @ $56.84 (-11.73% in 11 days)


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 29.65 +61.65% 160
2 21.24 +48.89% 49
3 19.00 +49.44% 205
4 17.77 +19.60% 4
5 15.63 +16.16% 6


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Pharmaceutical HOLDRs Trust Pharmaceutical HOLDRs Trust (PPH)
   SocialPicks Sentiment:    N/A

   This Quarter's Sentiment:
All:
50.0%
Top:
100.0%




Latest Picks by Mike Havrilla
Symbol SP Sentiment Rating Return Since
JNJ Positive -4.30% 11/22/08
GSK Positive -0.03% 11/22/08
FRX Positive +2.98% 11/21/08
CYPB N/A Positive +1.38% 11/21/08
VNDA Negative -13.11% 11/21/08

View All >
   
Mike Havrilla previously rated PPH
Positive -13.09% Healthcare ETFs Outpace the Market
11/01/2008
9
Positive +5.81% Generic Drug Industry Outpaces Drug & Healthcare ETFs
10/15/2008
9
Positive -4.47% Eli Lilly Sinks After Hours on Effient Delay
09/28/2008
3
Positive +0.70% Pfizer is a Big Pharma Buy
09/24/2008
3
Positive +0.30% Bristol-Myers Ups Bid to $62 for ImClone
09/23/2008
3
Positive -1.32% FDA Decision Date Calendar Through January 2009
09/21/2008
3





IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch